LUCENTIS for Age-related macular degeneration: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 248 adverse event reports in the FDA FAERS database where LUCENTIS was used for Age-related macular degeneration.
Most Reported Side Effects for LUCENTIS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 138 | 20.1% | 138 | 2 |
| Visual acuity reduced | 98 | 14.3% | 2 | 20 |
| Vision blurred | 64 | 9.3% | 2 | 14 |
| Cerebrovascular accident | 54 | 7.9% | 6 | 27 |
| Off label use | 54 | 7.9% | 2 | 8 |
| Eye pain | 43 | 6.3% | 1 | 3 |
| Visual impairment | 43 | 6.3% | 4 | 10 |
| Vitreous floaters | 42 | 6.1% | 2 | 11 |
| Blindness | 34 | 5.0% | 1 | 1 |
| Drug ineffective | 33 | 4.8% | 0 | 3 |
| Myocardial infarction | 33 | 4.8% | 8 | 16 |
| Cataract | 27 | 3.9% | 0 | 6 |
| Macular oedema | 26 | 3.8% | 0 | 3 |
| Retinal haemorrhage | 26 | 3.8% | 0 | 8 |
| Cataract nuclear | 20 | 2.9% | 0 | 5 |
Other Indications for LUCENTIS
Product used for unknown indication (191)
Diabetic retinal oedema (94)
Macular degeneration (51)
Retinal vein occlusion (51)
Diabetic retinopathy (35)
Retinal oedema (17)
Choroidal neovascularisation (11)
Macular oedema (11)
Cystoid macular oedema (10)
Diabetic eye disease (9)
Other Drugs Used for Age-related macular degeneration
AFLIBERCEPT (2,220)
RANIBIZUMAB (1,982)
BEVACIZUMAB (574)
BROLUCIZUMAB-DBLL (445)
VERTEPORFIN (256)
FARICIMAB\FARICIMAB-SVOA (185)
EYLEA (156)
FARICIMAB-SVOA (117)
BROLUCIZUMAB (73)
AVASTIN (67)